KDA
- Current
- Browse
- Collections
-
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
- About
- Editorial policy
Search
- Page Path
- HOME > Search
Review
- Cardiovascular Risk/Epidemiology
- Diabetes Management in Patients with Heart Failure
- Jia Shen, Barry H. Greenberg
- Diabetes Metab J. 2021;45(2):158-172. Published online March 25, 2021
- DOI: https://doi.org/10.4093/dmj.2020.0296
- 9,854 View
- 553 Download
- 8 Web of Science
- 11 Crossref
-
Graphical Abstract
Abstract
PDF
PubReader 
ePub - Diabetes and heart failure (HF) are common diseases, each affecting large segments of the world population. Moreover, prevalence rates for both are expected to rise dramatically over coming decades. The high prevalence rates of both diseases and wellrecognized association of diabetes as a risk factor for HF make it inevitable that both diseases co-exist in a large number of patients, complicating their management and increasing the risk of a poor outcome. Management of diabetes has been shown to impact clinical events in patients with HF and there is emerging evidence that agents used to treat diabetes can reduce HF events, even in non-diabetic patients. In this review we summarize the clinical course and treatment of patients with type 2 diabetes mellitus (T2DM) and HF and review the efficacy and safety of pharmacological agents in patients with T2DM at risk for HF and those with established disease.
-
Citations
Citations to this article as recorded by
- Letter to Editor From Banerjee et al: “Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure”
Mainak Banerjee, Indira Maisnam, Satinath Mukhopadhyay
The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e873. CrossRef - Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy
İnci Tuğçe Çöllüoğlu, Ahmet Çelik, Naim Ata, Dilek Ural, Anıl Şahin, Mustafa Mahir Ulgu, Emine Arzu Kanık, Şuayip Birinci, Mehmet Birhan Yılmaz
International Journal of Cardiology.2024; 407: 132109. CrossRef - COVID-19 Prevention and Mitigation Decision-Making Processes While Navigating Chronic Disease Care: Perspectives of Black Adults with Heart Failure and Diabetes
Leslie C. M. Johnson, Robina Josiah Willock, Sierra Simmons, Sarahna Moyd, Demetrius Geiger, Jalal K. Ghali, Rakale C. Quarells
Journal of Racial and Ethnic Health Disparities.2024;[Epub] CrossRef - Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
International Journal of Heart Failure.2023; 5(1): 1. CrossRef - Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)
Ali AlSahow, Mohammad AbdulShafy, Saeed Al‐Ghamdi, Harith AlJoburi, Osama AlMogbel, Fadel Al‐Rowaie, Nizar Attallah, Feras Bader, Hisham Hussein, Mohamed Hassan, Khaldoun Taha, Matthew R. Weir, Faiez Zannad
The Journal of Clinical Hypertension.2023; 25(3): 251. CrossRef - Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
Diabetes & Metabolism Journal.2023; 47(1): 10. CrossRef - Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register
Elena Succurro, Alessio Novella, Alessandro Nobili, Federica Giofrè, Franco Arturi, Angela Sciacqua, Francesco Andreozzi, Antonello Pietrangelo, Giorgio Sesti, Francesco Perticone, Francesco Violi, Salvatore Corrao, Alessandra Marengoni, Mauro Tettamanti,
Internal and Emergency Medicine.2023; 18(4): 1049. CrossRef - Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus
Jiaoran Li, Yanping Liu, Panpan Hao
Diabetes Research and Clinical Practice.2023; 202: 110798. CrossRef - Managing heart failure in diabetics with dual acting sotagliflozin—A review
Kushal Seni, Pooja A Chawla
Health Sciences Review.2023; 9: 100130. CrossRef - Effect of Integrated Care on Patients With Atrial Fibrillation: A Systematic Review of Randomized Controlled Trials
Yi Li, Wenjing Zhao, Jun Huang, Murui Zheng, Peng Hu, Jiahai Lu, Hai Deng, Xudong Liu
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef - Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond
Angela Sciacqua, Elena Succurro, Giuseppe Armentaro, Sofia Miceli, Daniele Pastori, Giuseppe Rengo, Giorgio Sesti
Heart Failure Reviews.2021; 28(3): 667. CrossRef
- Letter to Editor From Banerjee et al: “Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure”
First
Prev
